FDA Inspection
American Red Cross Blood ServicesAmerican Red Cross Blood Services – FDA Inspection, May 3, 2013
Record Details
This FDA Inspection record concerns American Red Cross Blood Services, with an inspection on May 3, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 3, 2013
- Product Type
- Biologics
View Company Profile
ID · 9c32c208-1a53-43b9-af8e-7587611412c8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 831874
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(b)Required records
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Red Cross Blood Services
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2026 | Not classified | New England District Office | |
| January 7, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 19, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 4, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Services
- FDA Inspection 1324182 - 2026-06-05
- FDA Inspection 1114962 - 2020-01-07
- FDA Inspection 1062469 - 2018-07-19
- FDA Inspection 944773 - 2015-09-17
- FDA Inspection 783488 - 2012-05-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.